SREBF2 and COVID-19: For example, SREBP2 activation is elevated in monocytes from COVID-19 patients, and its inhibitor, Fatostatin, suppresses the expression of pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6 [44,45].